Genethon;Centre d'Etude des Cellules Souches (CECS);Institut National de la Santé et de la Recherche Médicale;Universite d'Evry Val d'Essonne
发明人:
申请号：
EP19305097.8
公开号：
EP3685846A1
申请日:
2019.01.24
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to the use of a cyclic thiopeptide, advantageously thiostrepton or its derivatives, for treating a genetic disease linked to a conformational disorder of at least one protein, said disorder causing the cellular degradation of the protein.
